Career

Dec 24, 2024, 17:45

Narjust Florez and Scott Armstrong Received the 2025 Health Innovators Award for EQUAL Study at Dana-Farber Brigham Cancer Center

Narjust Florez, Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center, shared a post on X:

“2025 Health Innovators Award by the Boston Business Journal!

This work honors our EQUAL study which is an interception between translational oncology and community engagement

Thank you Boston Business Journal.”

Scott Armstrong

Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.

Scott Armstrong

Dr. Scott Armstrong is a Professor at Harvard Medical School and a prominent figure in pediatric oncology, biomedical research, and drug development. He has over 20 years of experience in clinical and academic settings, having served as a member of Memorial Sloan Kettering Cancer Center from 2012 to 2016.

Previously, Dr. Armstrong was an attending physician at both Dana-Farber Cancer Institute and Boston Children’s Hospital, with a background in pediatric hematology/oncology. He completed his MD, PhD in Medicine and Cell and Molecular Biology at the University of Texas Southwestern Medical School, where he was inducted into Alpha Omega Alpha. His career also includes roles as Associate and Assistant Professor at Harvard Medical School from 2003 to 2012.

Scott Armstrong